A Genetic Polymorphism in TOX3 Is Associated with Survival of Gastric Cancer in a Chinese Population

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Zhang, Xiaojing ^a,e   Zhu, Haixia ^b   Wu, Xiaomin ^a,f   Wang, Meilin ^c   Gu, Dongying ^a   Gong, Weida ^d   Xu, Zhi ^a   Tan, Yongfei ^d   Gong, Yongling ^a   Zhou, Jianwei ^c   Tang, Cuiju ^a   Tong, Na ^c   Chen, Jinfei ^a   Zhang, Zhengdong ^c,e  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nantong Cancer Hospital   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d Yixing Cancer Hospital   (China)

^e ZHEJIANG CANCER HOSPITAL   (China)

^f Yancheng No1 People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHINA; CHINESE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RISK REDUCTION; STOMACH CANCER; TOX3 GENE; TUMOR INVASION; TUMOR VOLUME;

ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PROGESTERONE; STOMACH NEOPLASMS;

EID: 84884258925     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072186     Document Type: Article

References (22)

1. Wang W, Bu XM, Wang J, Zhang N, Zhao CH, (2012) The expression of ARHI in pT2a and pT2b stage gastric cancer and its clinical significance. Oncol Rep 27: 1953-1959.
2. Chen X, Jiang K, Hu J, Zhang B, Gou H, et al. (2008) Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China. World J Gastroenterol 14: 2715-2722.
3. Meyer H, Wilke H, (2011) Treatment strategies in gastric cancer. Dtsch Arztebl Int 108: 698-705.
4. Kushi L, Byers T, Doyle C, Bandera E, McCullough M, et al. (2006) American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 56: 254-281.
5. Zhao Q, Wang W, Zhang Z, Wang S, Wang M, et al. (2011) A genetic variation in APE1 is associated with gastric cancer survival in a Chinese population. Cancer Sci 102: 1293-1297.
6. Wang M, Bai J, Tan Y, Wang S, Tian Y, et al. (2011) Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Int J Cancer 129: 1207-1213.
7. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, et al. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39: 865-869.
8. Yuan SH, Qiu Z, Ghosh A, (2009) TOX3 regulates calcium-dependent transcription in neurons. Proc Natl Acad Sci U S A 106: 2909-2914.
9. Dittmer S, Kovacs Z, Yuan S, Siszler G, Kögl M, et al. (2011) TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. J Cell Sci 124: 252-260.
10. Antoniou A, Spurdle A, Sinilnikova O, Healey S, Pooley K, et al. (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82: 937-948.
11. Gudmundsdottir ET, Barkardottir RB, Arason A, Gunnarsson H, Amundadottir LT, et al. (2012) The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients. BMC Cancer 12: 621.
12. Fasching PA, Pharoah PD, Cox A, Nevanlinna H, Bojesen SE, et al. (2012) The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet 21: 3926-3939.
13. Xu CY, Guo JL, Jiang ZN, Xie SD, Shen JG, et al. (2010) Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer. Ann Surg Oncol 17: 2503-2509.
14. Hohenberger P, Gretschel S, (2003) Gastric cancer. Lancet 362: 305-315.
15. Sobin L, Fleming I, (1997) TNM Classification of Malignant Tumors, fifth edition(1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804.
16. Xiao HW, Lai XY, Luo Y, Shi JM, Tan YM, et al. (2011) Relationship between TNFA, TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in a Chinese population. Bone Marrow Transplant 46: 400-407.
17. Vauhkonen M, Vauhkonen H, Sipponen P, (2006) Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 20: 651-674.
18. Liu L, Wu C, Wang Y, Zhong R, Wang F, et al. (2011) Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis. Carcinogenesis 32: 336-342.
19. Liu L, Wu C, Wang Y, Zhong R, Duan S, et al. (2011) Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival. J Thorac Oncol 6: 1793-1800.
20. Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, et al. (2011) Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 7: e1002171.
21. Riaz M, Berns EM, Sieuwerts AM, Ruigrok-Ritstier K, de Weerd V, et al. (2011) Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Res Treat.
22. Choi IK, Sung HJ, Lee JH, Kim JS, Seo JH, (2012) The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer. Cancer Chemother Pharmacol 70: 555-558.